Patents expiring in 2029

US 7521479

Methods of treating prion disease in mammals

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7521192

EDG: modulators of lymphocyte activation and migration

Rigel Pharmaceuticals, Inc. · Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7521414

Polyol macrolide antitumor-antibiotics from the marine actinomycete strain CNQ140

The Regents of the University of California · Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7521211

IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2702664

FORMULATION PHARMACEUTIQUE A LIBERATION CONTROLEE

ALPHAPHARM PTY LTD [AU] · Granted Thu Apr 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7524490

Clusterin-mediated inhibition of apoptosis via stromal bone marrow cell delivery to a cardiac site

The Board of Regents of the University of Texas System · Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7524944

Chimeric nucleic acids encoding polypeptides comprising CD154 and TNF-α

The Regents of the University of California · Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7524507

Recombinant microorganisms

The Secretary of State for Defence in Her Brittanic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland · Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7524499

Modified chimeric polypeptides with improved pharmacokinetic properties

REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7524962

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7524516

Corrosion inhibiting mildew remover kit

United States of America as represented by the Secretary of the Air Force · Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7524959

Biphenyl derivatives

Theravance, Inc. · Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7524965

Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

Theravance, Inc. · Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7524508

Subgenomic replicons of the flavivirus dengue

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7524880

Crystalline form of a substituted pyrrolidine compound

Theravance, Inc. · Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7524878

Phenyl substituted carboxylic acids

The Institute for Pharmaceutical Discovery, LLC · Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

AR 064864

COMPUESTOS ANALOGOS DE PIRIDINA VII 543 Y COMPOSICION FARMACEUTICA

ASTRAZENECA AB [SE] · Granted Wed Apr 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Apr 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7527802

Vaccine for transcutaneous immunization

The United States of America as represented by the Secretary of the Army · Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7527934

Labeled substrate conjugates for identifying enzyme inhibitors

The Regents of the University of California · Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7527786

Methods for inhibiting the growth of cancer cells expressing PSCA

The Regents of the University of California · Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7528138

Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7528202

Poly (ethylene glycol) derivatives with proximal reactive groups

Nektar Therapeutics AL, Corporation · Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7527952

Crystals of inosine monophosphate dehydrogenase/oxidized inosine monophosphate thiomidate intermediate/mycophenolic acid (IIMPDH/XMP*/MPA)

Vertex Pharmaceuticals Incorporated · Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7528118

RNAi modulation of ApoB and uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7528253

Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

Theravance, Inc. · Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7527797

Vibrio cholerae 0139 conjugate vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7528274

Acylthiols and component thiol compositions as anti-HIV and anti-retroviral agents

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7528142

Aminopyrimidines useful as kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7528133

Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation

The Board of Regents of the University of Texas System · Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7531523

Sodium channel protein type III alpha-subunit splice variant

Vertex Pharmaceuticals Incorporated · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7531500

Preventing airway mucus production by administration of EGF-R antagonists

The Regents of the University of California · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7531556

Compositions useful as inhibitors of rock and other protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7531635

MATER-protein specific antibodies and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7531341

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof

BIOMARIN PHARMACEUTICAL INC. · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7531536

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7531570

Treatment of diseases using ICE inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7531656

Synthesis of gatifloxacin

Teva Pharmaceuticals USA, Inc. · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7531514

Orally administered peptides synergize statin activity

The Regents of the University of California · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7531355

Methods and compositions for smooth muscle reconstruction

The Regents of the University of California · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7531623

Hydrochloride salts of a glycopeptide phosphonate derivative

Theravance, Inc. · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7531352

Inducible plasmid vector encoding TGF-β and use thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7531173

Ophthalmic composition of a VEGF antagonist

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7531172

Methods of treating diseases with a VEGF antagonist

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7531162

Transcobalamin receptor binding conjugates useful for treating abnormal cellular proliferation

Regents of the University of Minnesota · Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2057147

PYRIMIDIN-DERIVATE

ASTRAZENECA AB [SE] · Granted Wed May 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue May 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

AR 065042

DERIVADOS DE CINNOLINA, PROCESOS DE OBTENCION Y COMPOSICIONES FARMACEUTICAS

ASTRAZENECA AB [SE] · Granted Wed May 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue May 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7534440

Fusion molecules and methods for treatment of immune diseases

The Regents of the University of California · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7534889

5-HT4 receptor agonist compounds

Theravance, Inc. · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)